N-(Phenylacetyl-d5)glycine CAS号: 1189920-31-7 英文名: N-(Phenylacetyl-d5)glycine 英文别名: N-(Phenylacetyl-d5)glycine;UTYVDVLMYQPLQB-RALIUCGRSA-N;2-[[2-(2,3,4,5,6-pentadeuteriophenyl)acetyl]amino]acetic acid 中文名: N-(Phenylacetyl-d5)glycine 中文别名: N-(苯乙酰基-D5...
别名N-(苯乙酰基)甘氨酸 英文别名HY-W015061 | Phenacetylglycine | N-Phenacetylglycine | Cambridge id 5117723 | Phenaceturate | bmse000658 | 2-(2-Phenylacetamido)Acetic Acid | EINECS 207-916-1 | N-(2-PHENYLACETYL)GLYCINE | P0131 | PHENATURIC ACID | C05598 | GLYCINE, N-(2-PHENYLACETYL...
Previously designed cyclo-L-prolylglycine (CPG), a peptide prototype of piracetam, was discovered as an endogenous compound in rat brain and exhibited nootropic and anxiolytic properties. N-Phenylacetdoi:10.1007/s11094-017-1516-4Gudasheva, T. A....
N-phenylacetyl-L-prolylglycine ethyl ester (brand name: Noopept), a Nootropic molecule similar to Piracetam that may alleviate cognitive decline.
Glycine, N-(2-cyanoethyl)-N-[(2R)-2-methoxy-2-phenylacetyl]-, ethyl ester CBNumber: CB94694077 Molecular Formula: C16H20N2O4 Molecular Weight: 304.34 MDL Number: MOL File: 1630074-24-6.mol Request For QuotationProperties Suppliers 1 Glycine...
66434-35-3 化学名称 Glycine, N-(cyclohexylphenylacetyl)- (9CI) CAS No.66434-35-3 分子式C16H21NO3 分子量275.348 查看所有 66434-35-3 性质 66434-35-3 供应商 SAGECHEM LIMITED Glycine, N-(cyclohexylphenylacetyl)- Appearance: Purity:95% FOB Price: / 发送询盘 查看所有...
nootropic Noopept N-Phenylacetyl-L-prolylglycine ethyl ester 99% HPLC CAS 157115-85-0,USD,10/Gram,cas No:157115-85-0,Formula:C17H22N2O4, Purity 99.5% - KINGFENG TECHNOLOGY LIMITED
Previously designed cyclo-L-prolylglycine (CPG), a peptide prototype of piracetam, was discovered as an endogenous compound in rat brain and exhibited nootropic and anxiolytic properties. N-Phenylacetylglycyl-L-proline ethyl ester (GZK-111) was synthesized in the present work. It was established ...
A composition comprising a combination of N-Phenylacetyl-L-prolylglycine ethyl ester and cannabidiol for oral administration to humans and other animals and a method for administering said composition are described. The composition provides synergistic nootropic benefits to the user, resulting in enhanced...
The invention also discloses a preparation method of N-(1-(phenylacetyl)-L-prolyl)glycine ethyl ester. Operation of the preparation methods is simple; and preparation efficiency is high.严建祥张卫军